Literature DB >> 9474465

Immunosuppressive therapy for peripartum-type spontaneous coronary artery dissection: case report and review.

P T Koller1, C M Cliffe, D J Ridley.   

Abstract

BACKGROUND: A 35-year-old postpartum woman presented with myocardial infarction (MI) due to spontaneous coronary artery dissection (SCAD). In addition to conventional medical therapy, she was treated with immunosuppressive agents (prednisone and cytoxan) because of five noncontiguous coronary dissections, surgical inoperability, and postinfarction angina. Repeat angiography 94 days later demonstrated angiographically normal vessels.
METHODS: A literature review of 42 additional cases of peripartum SCAD was performed, and the results were compared with this patient.
RESULTS: Mortality was 48.8% (21/43). Sudden cardiac death was the initial presentation in 27.9% (12/43) of cases. The left coronary artery was involved in 78.6% (44/56) of dissections with left main segment dissection in 10 cases. In women who survived > 24 h post infarction, recurrent MI, usually due to a second coronary dissection, occurred in 20.8% (5/24). Histopathologic studies have often shown periadventitial inflammation (80%, 16/20), in which eosinophils predominate (68.8%, 11/16), and may be linked to the medial degeneration often found in these cases.
CONCLUSIONS: The common observation of eosinophilic periadventitial inflammation suggests a role in the pathophysiology of this rare, yet serious condition. Aggressive immunosuppressive therapy in this case of multivessel dissection resulted in spontaneous angiographic healing of all lesions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9474465      PMCID: PMC6656028          DOI: 10.1002/clc.4960210108

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  30 in total

1.  Spontaneous coronary artery dissection: an uncommon but dangerous condition.

Authors:  Joseph S Alpert
Journal:  Curr Cardiol Rep       Date:  2004-07       Impact factor: 2.931

2.  Recurrent spontaneous coronary artery dissection: A case report and review of the literature.

Authors:  Jacqueline L Harris; John Brereton; Cathy S Lim; Gregory Ic Nelson
Journal:  Int J Angiol       Date:  2007

3.  Recurrent spontaneous coronary artery dissection: acute management and literature review.

Authors:  James Alexander Rosengarten; Ali Dana
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-04

4.  "The scaffolding must be removed once the house is built"-spontaneous coronary artery dissection and the potential of bioresorbable scaffolds.

Authors:  Keyvan Karim Galougahi; Ori Ben-Yehuda; Akiko Maehara; Gary S Mintz; Gregg W Stone; Ziad A Ali
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

5.  Spontaneous coronary artery dissection as a cause of sudden cardiac death in the peripartum period.

Authors:  Jatinder Singh Pabla; Lawrence John; William A McCrea
Journal:  BMJ Case Rep       Date:  2010-12-01

6.  [Chest pain at 32 weeks' gestation: pregnancy-related spontaneous coronary artery dissection].

Authors:  A Schmutz; P Quaas; S Grundmann
Journal:  Anaesthesist       Date:  2016-08-02       Impact factor: 1.041

Review 7.  Spontaneous Coronary Artery Dissection and Pregnancy.

Authors:  Sahar Naderi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09

8.  Spontaneous coronary artery dissection in a young man with a factor v leiden gene mutation: a case report and review of the literature.

Authors:  Tahir Khan; Peter Danyi; On Topaz; Asghar Ali; Ion S Jovin
Journal:  Int J Angiol       Date:  2013-12

9.  A Spontaneous Coronary Artery Dissection Case Noticed during a Primary PCI.

Authors:  Ismail Dogu Kilic; Halil Tanriverdi; Harun Evrengul; Sukru Gur
Journal:  Cardiol Res Pract       Date:  2010-03-07       Impact factor: 1.866

10.  Should we establish a new protocol for the treatment of peripartum myocardial infarction?

Authors:  Philip D Houck; William J Strimel; D Scott Gantt; Walter J Linz
Journal:  Tex Heart Inst J       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.